Probe Substantiates Allegations Against WEF's Schwab, SZ Reports
According to excerpts seen by the newspaper, law firm Homburger found that Schwab repeatedly intervened to influence country rankings in the WEF's Global Competitiveness Report for political purposes, the newspaper reported, citing excerpts it had seen. In one 2017 email to then-managing director Richard Samans, Schwab allegedly requested that the report be withheld to avoid straining his relationship with Indian Prime Minister Narendra Modi, due to the country's poor performance in the ranking, SonntagsZeitung said. Schwab also advised against improving the UK's place to prevent it being exploited by the supporters of Brexit, the newspaper said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Wegovy, Mounjaro sales in India double on month in July
By Rishika Sadam and Kashish Tandon HYDERABAD (Reuters) -Sales of Danish drugmaker Novo Nordisk's Wegovy and U.S. rival Eli Lilly's Mounjaro in India doubled in July from a month earlier, data from research firm Pharmarack showed on Thursday. Demand for the blockbuster anti-obesity drugs, which help control blood sugar and slow digestion, has been on an upswing in the world's most populous nation. Sales of Wegovy, launched locally in June, more than doubled to 5,000 units or 70 million rupees ($798,230) in July, the data showed. Mounjaro sales also doubled month-on-month to 157,000 units or 470 million rupees. "Though Wegovy has a strong prescriber base because of Rybelsus, substantial promotion may be needed to reach the Mounjaro patient base for the injectable market," Pharmarack's Vice President (Commercial) Sheetal Sapale said in a statement. In India, Novo has been selling oral semaglutide pills under the brand name Rybelsus since 2022 for type 2 diabetes. Mounjaro's sales have soared 15 times since March, when the drug was launched in India. ($1 = 87.6790 Indian rupees) Sign in to access your portfolio
Yahoo
9 minutes ago
- Yahoo
Blackburn Rovers given update after latest Venky's India court hearing
Venky's court case against the Indian Ministry of Finance has been delayed for the seventh time this calendar year. The Blackburn Rovers owners have been embroiled in court battles with the Indian government since 2023. It is the seventh time since the turn of the year that the Court of Delhi has pushed back the hearing against VHPL, Venky's parent company. The latest was supposed to be heard on Tuesday, August 5, but once again, it didn't make the cut. It has now been rearranged for the 12th of November, 2025. The official documents released state: "The matter could not be taken up today due to paucity of time. List on 12.11.2025." READ MORE: The latest delay comes as little surprise given the previous postponements but continues to be a frustration for the club and owners. There is a cost of around 25K each time the case goes to court, regardless of whether it is heard, which racks up over time. A major part of the issue is that there are only four judges across the country to hear these cases. Therefore, they can drag on for a number of years, as has been playing out but the owners have continued to show no appetite to sell the club. Blackburn Rovers officials have always reiterated that there are no barriers preventing Venky's from funding the club. In 2023, VHPL secured a No-Objection Certificate, which allows money to be sent if every pound is matched with a personal guarantee. The owners most recently sent over £4.85million in funding in May to cover the summer months' liabilities. The personal guarantee was reduced to 50% for that money, meaning that the additional payment was halved. The Lancashire Telegraph understands that remains the case for every transaction moving forward, which eases the burden somewhat. Venky's, understandably, will continue to put forward their case for that to be removed. Until that's approved, money sent to Rovers will continue to cost them half the value in addition. It's thought that as much as £25m is sat in the bond. Rovers' summer transfer business has never been dependent on the outcome of this court case. Budgets were agreed months ago and the club will continue to be active in the final three weeks of the window. Fees have been spent on all six of the club's summer signings, ranging from hundreds of thousands to seven-figure sums. A right-winger is their priority in the remaining 25 days, with cover at centre-back also a consideration after Hayden Carter's injury. Valerien Ismael told The Lancashire Telegraph that Callum Brittain's departure should give Rovers more 'freedom' in the market too, though the deals they were pursuing were not dependent on his sale. Whilst a dip into the loan market has not been ruled out, Rovers officials are keen for the club to make permanent signings to avoid developing other team's players.
Yahoo
9 minutes ago
- Yahoo
Alchemy spots window to sell home improvements group Anglian
The backer of one of Britain's biggest home improvement specialists is plotting a sale that would close the door on one of the longest ownership periods in the private equity industry's history. Sky News has learnt that Alchemy Partners is preparing to appoint investment bankers to sell Anglian Home Improvements, the provider of windows, doors and home extensions. Sources said an auction of the business was likely to kick off in the next 12 months. Money latest: One source estimated that the company could be worth in excess of £100m, although a more precise valuation was unclear on Thursday. Alchemy, which specialises in acquiring distressed businesses before improving their performance and selling them on, has owned Anglian in various forms since 2001. The company has been reshaped several times since its original investment. Alchemy took Anglian private in 2001 through a recommended cash offer worth about £160m. At the time, Alchemy was run by Jon Moulton, one of the pioneers of Britain's private equity industry and who later went on to own Anglian's rival double-glazing, Everest, through his subsequent buyout venture, Better Capital. Since then, Anglian has swooped on a number of troubled rivals, including Safestyle in 2023, before acquiring Everest's brand and other assets the following year. Alchemy declined to comment.
